I thought the bad news was the possibility of another capital raising to fund taking SNT 5505 through Phase 3, unless Syntara can get a partner ( but that's always been the risk ) NB: Assumption being that SNT 5505 meets its primary endpoint(s).
Yes, has always been and is the risk. I bought in in May knowing that we are only funded until mid-2025, so not new bad news at least!In any event, having 4 x phase 2's on the go helps reduce the risk.
Add to My Watchlist
What is My Watchlist?